ConductScience.org, home

Paper3142013

Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms.

Quinn JP and 3 others. Rev Infect Dis, 1988. Cited by 70 papers, by iCite.

Cite this record

ConductScience Library. Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms. Papers, record 3142013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3142013

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms.
PubMed
Journal
Rev Infect Dis
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
70
iCite
Relative citation ratio, by iCite
3.44
iCite
Revised in PubMed
2019-08-28
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Quinn JPJ P
2Studemeister AEA E
3DiVincenzo CAC A
4Lerner SAS A

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ImipenemMajor topic
Pseudomonas InfectionsMajor topic
Pseudomonas aeruginosaMajor topic
Drug Resistance, Microbial
Humans
beta-Lactamases

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AI-07099NIAID NIH HHSUnited StatesPubMed

Source PubMed

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01570192Clinical Trials to Reduce the Risk of Antimicrobial ResistanceBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.

PMIDTitleJournalYearIn PapersSource
42598182Pharmacodynamic modeling of colistin and imipenem against in vitro Pseudomonas aeruginosa biofilms.Biofilm2026https://conductscience.org/library/papers/42598182PubMed
24336826In memoriam: John P. Quinn, MD.Clin Infect Dis2014https://conductscience.org/library/papers/24336826PubMed
19822890Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Clin Microbiol Rev2009https://conductscience.org/library/papers/19822890PubMed
18983709Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use.Crit Care2008https://conductscience.org/library/papers/18983709PubMed
16517923Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia.J Clin Microbiol2006https://conductscience.org/library/papers/16517923PubMed
15561840Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15561840PubMed
8408557Influence of zinc on Pseudomonas aeruginosa susceptibilities to imipenem.J Clin Microbiol1993https://conductscience.org/library/papers/8408557PubMed
8141574Retain intermittent dosing of carbapenems.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8141574PubMed
8117090Chemotaxis to oligopeptides by Pseudomonas aeruginosa.Appl Environ Microbiol1994https://conductscience.org/library/papers/8117090PubMed
8050431Imipenem resistance among gram-negative bacilli.Eur J Clin Microbiol Infect Dis1994https://conductscience.org/library/papers/8050431PubMed
7726503Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7726503PubMed
7648757Meropenem clinical pharmacokinetics.Clin Pharmacokinet1995https://conductscience.org/library/papers/7648757PubMed
2109575Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa.Antimicrob Agents Chemother1990https://conductscience.org/library/papers/2109575PubMed
2039198Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/2039198PubMed
1645509Resistance to pefloxacin in Pseudomonas aeruginosa.Antimicrob Agents Chemother1991https://conductscience.org/library/papers/1645509PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3142013

GET https://conductscience.org/api/papers/v1/3142013/authors